The antioxidant potential of salicylaldehyde-derived imines was evaluated and cytotoxicity was assessed, revealing that the chlorinated derivatives such as I5 combine moderate anticancer activity with lower toxicity toward non-tumor cells (Vero IC50 > 400 µM).
Abstract
Imines, commonly known as Schiff bases, are widely investigated compounds because of their structural versatility and biological properties. In this study, we aimed to evaluate the antioxidant potential of salicylaldehyde-derived imines and to determine how their reduction to the corresponding secondary amines affects their radical-scavenging activity and mechanism of action. Two series of phenolic derivatives, imines I1–I6 and amines A1–A6, were synthesized and assessed using an integrated experimental and theoretical strategy combining five in vitro antioxidant assays with density functional theory calculations. Antioxidant evaluation by DPPH, ABTS, FRAP, phenanthroline, and CUPRAC assays revealed distinct activity profiles for the two series. The imine derivatives were more effective in electron-transfer-based assays, whereas the reduced amines showed stronger DPPH radical-scavenging activity. Compound A6 exhibited the highest overall antioxidant activity, with IC50 values (e.g., DPPH IC50 = 26.7 ± 0.97 µM; ABTS IC50 = 11.69 ± 0.43 µM) lower than BHT (DPPH IC50 = 85.85 ± 3.69 µM) and BHA (DPPH IC50 = 59.39 ± 1.9 µM) in most assays. DFT calculations in aqueous medium indicated that the phenolic OH groups govern antioxidant reactivity and identified SPLET as the dominant mechanism for A6, supported by a remarkably high rate constant (k = 1.40 × 105 M−1s−1) and a 100% branching ratio (G), completely outcompeting the HAT mechanism (k = 2.28 × 10−2 M−1s−1). In addition to the antioxidant investigation, cytotoxicity was assessed in MDA-MB-231 breast cancer cells and Vero normal cells, revealing that the chlorinated derivatives such as I5 combine moderate anticancer activity (MDA-MB-231 IC50 = 122.6 ± 2.23 µM) with lower toxicity toward non-tumor cells (Vero IC50 > 400 µM). Molecular docking studies were conducted to elucidate the binding modes of the active derivatives within the active sites of EGFR, Tubulin, and Topoisomerase IIβ, while subsequent 100 ns molecular dynamics simulations validated the structural stability and sustained interaction energies of these predicted complexes.
The determined biological activities of Schiff base derivatives obtained from 4-aminoantipyrine via condensation with various aromatic and heteroaromatic aldehydes support these derivatives as promising multifunctional scaffolds for the development of novel antibacterial and anticancer agents.
M. I. Sultan, Muthanna C. Urabee, A. Sadiq et al.· Journal of Genetic Engineeri...· 0 citations
The results show that the synthesized sulfamethoxazole-based compounds, based on sulfamethoxazole, are attractive can-didates for the development of novel antioxidant and antibacterial drugs.
Khitam Ahmed, H. Al-Adhami, Zainab Sallal et al.· Journal of the Turkish Chemi...· 0 citations
The results indicate that the thiazole-benzodioxole scaffold is a promising framework for developing multifunctional agents with combined neuroprotective, antidiabetic, and antioxidant activities.
Tuğçe Çaklılı, Yusuf Sıcak, Somdatta Y. Chaudhari et al.· Pharmaceuticals· 0 citations
Novel thiazolyl–polyphenolic derivatives were designed and synthesized to investigate the influence of aromatic substituents on antioxidant activity, molecular properties, and cytotoxicity. Eight derivatives (E1–E8) were synthesized by a Hantzsch reaction and their structures were confirmed by MS, FT-IR, and 1H/13C NMR...
A. Cornea, Gabriel Marc, I. Fizeșan et al.· Molecules· 0 citations
The hydroxyl-containing Schiff base derivatives demonstrated remarkable biological potential, especially antioxidant and antimicrobial activities, which indicated clear differences between Gram-positive and Gram-negative bacteria.
O. Gundogdu, Sertan Aytaç, Kubra Ozturk et al.· Celal Bayar Universitesi Fen...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.